Zhao Chenqi, Fernandes Maria J, Turgeon Mélanie, Tancrède Sabrina, Di Battista John, Poubelle Patrice E, Bourgoin Sylvain G
Centre de Recherche en Rhumatologie et Immunologie, Centre de Recherche du CHUQ-CHUL, Départements d'Anatomie-Physiologie et Médecine, Faculté de Médecine, Université Laval, Québec, Canada, G1V 4G2.
J Lipid Res. 2008 Nov;49(11):2323-37. doi: 10.1194/jlr.M800143-JLR200. Epub 2008 Jul 24.
Sphingosine-1-phosphate (S1P), via interaction with its G protein-coupled receptors, regulates various physiological and pathological responses. The present study investigated the role of S1P/S1P receptor signaling in several functional responses of human fibroblast-like synoviocytes (FLSs) that may contribute to the pathogenesis of rheumatoid arthritis (RA). We report that FLSs express the S1P(1), S1P(2), and S1P(3) receptors. Moreover, exogenously applied S1P induces FLS 1) migration, 2) secretion of inflammatory cytokines/chemokines, and 3) protection from apoptosis. Using specific S1P receptor agonists/antagonists, we determined that S1P stimulates FLS migration through S1P(1) and S1P(3), induces cytokine/chemokine secretion through S1P(2) and S1P(3), and protects from cell apoptosis via S1P(1). The S1P-mediated cell motility and cytokine/chemokine secretion seem to be regulated by the p38 mitogen-activated protein kinase (MAPK), p42/44 MAPK, and Rho kinase signal transduction pathways. Interestingly, treatment of FLSs with tumor necrosis factor-alpha increases S1P(3) expression and correlates with the enhancement of S1P-induced cytokine/chemokine production. Our data suggest that S1P(1), S1P(2), and S1P(3) play essential roles in the pathogenesis of RA by modulating FLS migration, cytokine/chemokine production, and cell survival. Moreover, the cytokine-rich environment of the inflamed synovium may synergize with S1P signaling to exacerbate the clinical manifestations of this autoimmune disease.
鞘氨醇-1-磷酸(S1P)通过与其G蛋白偶联受体相互作用,调节各种生理和病理反应。本研究调查了S1P/S1P受体信号传导在人成纤维样滑膜细胞(FLS)的几种功能反应中的作用,这些反应可能与类风湿性关节炎(RA)的发病机制有关。我们报告称,FLS表达S1P(1)、S1P(2)和S1P(3)受体。此外,外源性应用S1P可诱导FLS:1)迁移;2)分泌炎性细胞因子/趋化因子;3)免受凋亡。使用特异性S1P受体激动剂/拮抗剂,我们确定S1P通过S1P(1)和S1P(3)刺激FLS迁移,通过S1P(2)和S1P(3)诱导细胞因子/趋化因子分泌,并通过S1P(1)保护细胞免受凋亡。S1P介导的细胞运动和细胞因子/趋化因子分泌似乎受p38丝裂原活化蛋白激酶(MAPK)、p42/44 MAPK和Rho激酶信号转导途径调节。有趣的是,用肿瘤坏死因子-α处理FLS会增加S1P(3)表达,并与S1P诱导的细胞因子/趋化因子产生增强相关。我们的数据表明,S1P(1)、S1P(2)和S1P(3)通过调节FLS迁移、细胞因子/趋化因子产生和细胞存活,在RA发病机制中起重要作用。此外,炎症滑膜中富含细胞因子的环境可能与S1P信号协同作用,加剧这种自身免疫性疾病的临床表现。